News

Fostamatinib (previously referred to as R788), is thought to reversibly block signalling in multiple cell types involved in inflammation and tissue degradation in RA. The first anticipated regulatory

Before joining the company, Guggenhime served as senior vice president and CFO of at Facet Biotech and as PDL BioPharma as senior vice president and CFO. During his

The company has posted a net loss of $4.24m for the fourth quarter 2010, or $0.40 loss per diluted share, compared to net loss of $200,530, or $0.02loss

The Vector TFC Roll Compactor is a versatile densification and dry granulation machine that produces uniform compacted sheets with consistent hardness and increased density by compacting powdered material

In his position, Elam will drive customer satisfaction and continue to expand Capitol’s involvement in local, national and international markets. Before joining Capitol Scientific, Elam worked as a

In his position, Elam will drive customer satisfaction and continue to expand Capitol’s involvement in local, national and international markets. Before joining Capitol Scientific, Elam worked as a

The ERP implementation is expected to consolidate all functions on to a single platform, improve financial reporting and provide better inventory visibility across organisation as well as flexibility

As per the terms of the contract, ATS will continue to provide software development services for the NCI Center for Biomedical Informatics and Information Technology (CBIIT) in support

As per the agreement, Valeant stockholders will receive, for each share of Valeant common stock outstanding immediately prior to the merger, 1.7809 Biovail common shares. The combined company,